Positron Emission Tomography or PET scanners are medical imaging systems used for functional molecular imaging and quantification of biological processes in the body. PET scans provide precise diagnostic information by detecting positron-emitting radioactive tracers (radiotracers) administered to the patient, allowing visualization and measurement of normal and abnormal functional processes.
The global Positron Emission Tomography Scanners Market is estimated to be valued at US$ 2.5 Bn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends: The increasing demand for early and accurate disease diagnosis as well as treatment monitoring and evaluation is a key factor driving the growth of positron emission tomography scanners market. PET scans can detect the changes at molecular and cellular levels even before anatomical changes are visible on other imaging technologies, allowing for early diagnosis and prevention or pre-emptive treatment of diseases. For example, PET scans are being extensively used in the diagnosis of neurological disorders such as Alzheimer’s and cancer for detection of tumors, recurrence monitoring after treatment and assessing treatment response. As the prevalence of chronic diseases continues to rise worldwide, the demand for improved disease management technologies such as PET scanners is also growing considerably.
SWOT Analysis
Strength: Positron emission tomography scanners offer high sensitivity and resolution. They can provide early detection of various types of cancers.
Weakness: PET scans are expensive and require the use of radioactive tracers. Availability of these scanners is also limited in some regions.
Opportunity: Growing prevalence of cancers and cardiac diseases is driving the demand for PET scans. Technological advancements are also helping to improve scanner designs.
Threats: Stringent regulations around the use of radioactive materials. Presence of alternative imaging modalities like MRI and CT scanners.
Key Takeaways
The global Positron Emission Tomography Scanners market is expected to witness high growth. The global Positron Emission Tomography Scanners Market is estimated to be valued at US$ 2.5 Bn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030.
The North America region currently dominates the market owing to high adoption of advanced medical technologies and high healthcare spending. Asia Pacific is expected to grow at the fastest rate during the forecast period due to increasing cancer incidence, rising disposable incomes, expanding medical tourism industry and growing investments by key players in developing healthcare infrastructure in emerging countries.
Key players operating in the Positron Emission Tomography Scanners market are Positron Corporation, CellSight Technologies, RefleXion, Clarity Pharmaceuticals, PETsys Electronics SA, Blue Earth Diagnostics Limited, Qubiotech Health Intelligence S.L., Advanced Accelerator Applications, Lily, Agfa-Gevaert Group, CMR Naviscan, Neusoft Corporation, Siemens, Segamicorp, ONCOVISION, MedX Holdings, Modus Medical Devices, Radiology Oncology Systems, TOSHIBA CORPORATION, and General Electric Company, among others.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.